Use of alkylaryl polyether alcohol polymers for the inhibition of nuclear transcription factor nf-xb
CA 2251384 A1 · Owner: The University Of Utah · Inventors: Kennedy, Thomas P.; Ghio, Andrew J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method and medicant for the inhibition of activation of the nuclear transcription NF-B comprising administering an effective amount of a compound of formula (I) where R = ethylene, R~= C4 to C14 straight chain or branched alkyl, x is greater than 1, and y = 8 to 18 is provided. The medicant is , preferably administered by aerosolization into the mammalian respiratory system. The medicant may also be applied to the mammalian skin. Preferably the medicant includes a physiologically acceptable carrier which may be selected from buffered saline, isotonic saline normal saline, petroleum-based , ointments and U.S.P. cold cream. There is further provided a method wherein said medicant …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 14, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 14, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 14, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.